Wednesday, November 21, 2012

QUANTUM MAGNETIC RESONANCE THERAPY IN CANCER MANAGEMENT — AN OVERVIEW


The next presentation was by Dr. G.S. Nayar Founder Director Anytime Medicare Services Pvt. Ltd., Bangalore
QUANTUM MAGNETIC RESONANCE THERAPY IN CANCER MANAGEMENT — AN OVERVIEW
Introduction to Dr. Nayar :  Dr. Nayar served the Armed Forces Medical Service in the Indian Air Force for over three decades, in areas of Specialist aero-medical and family practice, teaching, research and clinical applications of technology. His expertise and experience as a Senior Advisor (Aviation Medicine) and Professor (Aerospace Medicine) at the Institute of Aerospace Medicine and Rajiv Gandhi University of Health Sciences Bangalore helped him to shape the Ojus concept. An enthusiastic advocate of technology, Dr. Nayar's zeal has manifested itself in the form of wide spread ICT and medical technology usage in most of the care programs in Ojus.
Dr. Nayar began his presentation with an overview introduction of OJUS.
Ojus Healthcare Private Limited is a Bengaluru-based care provider committed to delivering comprehensive, cost effective primary care to citizens from all walks of life. Established in 2001, Ojus currently owns and operates a chain of clinics in the states of Karnataka and Kerala, specialized in corporate, residential and school healthcare. Ojus services are used by major Information Technology companies located in Tech Parks such as Info Tech Park Bangalore, Bagmane Tech Park Bengaluru, Technopark Thiruvananthapuram, and Infopark Kochi to name a few. Residents of the Sobha Lakeview Apartment Complex and students of Deen's Academy, both at Bengaluru , are some of our other esteemed care recipients.
Ojus also provides specialized treatment using the Cytotron ®, a state-of-the-art tissue engineering technology and medical system, for treating Degenerative Arthritis and advanced Cancers.
Dr. Nayar continued his presentation with introduction to tissue engineering and Cytotron. Cytotron is a device developed for Tissue Regeneration, Degeneration and Repair for the purposes of treating several chronic or degenerative diseases such as Cancer & Arthritis. The treatment modality is non-invasive, painless and free from side effects. Cytotron has been a great breakthrough in tissue engineering.  He also elaborated on functioning of the Nucleoproteins with cell growth, molecular medicine and Nano medicine.  The goal of this field is to understand and re-direct natural processes for repair of damaged DNA, as well as to reengineer to provide a clinically applicable gene correction technology.
RFQMR (Rotational Field Quantum Nuclear Magnetic Resonance) is the technology and Science behind a process and CYTOTRON is a device that produces and delivers RFQMR.
CYTOTRON is a huge machine, which looks like a modern whole body MRI scanner but has a bigger bore. The bore has a gantry that carries about 864 guns (older versions have 288 guns). Each of the guns produces high instantaneous magnetic field and radio frequency, it also consist of a special near field antenna and parabolic reflectors to deliver these signals. These guns emit packets or Quantum of programmed signals in time and space that are focused to the target of interest using laser guides. These emitted string of packets, which contain the dosimetry required for a specific medical condition is delivered by the antenna. The beams are than rotated in 360 degrees around the target.

The patient is made to lie down on a traveling bed, the bed travels into the bore of the CYTORTON, the laser guides come on and the technician focuses the guns as per a pre-prepared template. The secondary dosimetry that is prepared by a trained Doctor is initiated from the control room, and the CYTOTRON starts its job. After completing the assigned dose of radiation, the device automatically stops. The patient is than removed out of the bore.
The functioning of Cytotron on cancer cells
Cancer cells are cells that have lost control, by overriding the rule of DNA they keep multiplying uncontrollably.  Every cell of our body has a DNA that controls the functioning of our body through the cells. With mutations in cells, the code is overrun and there is chaos as rules are not being followed by cells. Our immune system and drug therapies try to fix the problem with the mutate cells but do not succeed always, especially in cases of cancer.
In a way RFQMR uses specific dosimetry to retune cellular signaling programs and restore optimal cell functions. Normal cells restart following RFQMR exposure without a problem because their DNA is normal. However, the cancer cells with multiple defects in the DNA (i.e. mutations, chromosome alterations and viruses) prevent its retuning, which would cause tumor cells to stop growing or commit suicide.
Rotational Field Quantum Magnetic Resonance (RFQMR) technology utilized highly complex quantum electromagnetic beams in the sub-radio and near-radio frequency spectrum. The beams are precisely controlled and focused onto tissues to alter the proton spin inside and outside the cells therein generating streaming voltage potentials. This alters cell membrane potential and "Jams" the "Command and Control" of the target tissue cells stimulating cartilage growth.
The team that developed Cytotron after years of research at CARD was headed by Dr Rajah Vijay Kumar DSc.  Dr Kumar is a pioneering researcher and an opinion leader in the field of Biophysics and Radiobiology. Specialized in Medical Engineering, he has worked for more than fifteen years on regenerative tissue engineering and high speed biological data acquisition, modeling and simulation of the human cardiovascular system.
RFQMR technology utilizes a totally different approach compared to conventional cancer treatments. Instead of the very high frequency ionising radiation used in radiotherapy RFQMR uses radio or sub-radio frequency, low power, non-ionising, non thermal electromagnetic waves.
Dr. Nayar presented the delegates of the seminar with clinical profile of the patients who have undergone the treatment under this technology. With one patient whose toe had been severed, with the help of latest tissue engineering technology, the medical team had grown the toe back. Dermal replacement techniques can now restore original tissue to those who have lost it to trauma, disease, or other accidental causes.
A phase 1 clinical study has been held at the Institute of Aerospace Medicine in Bangalore India between 2004 and 2006 on more than 100 terminal cancer patients. All patients were undergone all possible conventional interventions such as chemo, radiotherapy or surgery prior to RFQMR and yet the disease cannot be controlled and they are supposed to die within a few days to few months due to cancer. Out of such patients:
·         There is a 90% symptomatic relief (such as ease of pain, stop using pain killers, no more weight loss etc)
·         In most of the patients the tumor progression is stopped or reversed
·         More than 60% survived more than 1 year
·         More than 35 % went back to normal lives and living disease free for 2 years
 According to Dr. Dr. Rajah V. Kumar, out of the treated Terminal Cancer patients, the one year survival rate was 52% (including patients who died of heart attacks kidney failure etc.,) while 92% of the patients had improved quality of life, for whatever period they lived. All their research outcomes are audited by International third party audit and not the mere analysis of the project investigators.
Dr. Nayar ended his presentation by explaining the applications of Cytotron in various treatments.
Conditions Treateable with Cytotron
Initially Clinical Studies were focused on Osteoarthritis and Cancer. As Tissue engineering can be applied to almost every part of the body and treats at the very basic level the potential applications will be:
http://www.cytotron.com/images/cytotron_clip_image001.jpgStimulation of Angiogenic Growth Factor and promoting Coronary and peripheral pro-angiogenesis 
http://www.cytotron.com/images/cytotron_clip_image001_0000.jpgOsteo-arthritis
http://www.cytotron.com/images/cytotron_clip_image001_0001.jpgRelieving pain, and disability due to trauma 
http://www.cytotron.com/images/cytotron_clip_image001_0002.jpgCarpal tunnel syndrome
http://www.cytotron.com/images/cytotron_clip_image001_0003.jpgOsteoporosis
http://www.cytotron.com/images/cytotron_clip_image001_0004.jpgPain management / Fibromyalgia 
http://www.cytotron.com/images/cytotron_clip_image001_0005.jpgMigraine
http://www.cytotron.com/images/cytotron_clip_image001_0006.jpgDiabetes, Diabetic neuropathy
http://www.cytotron.com/images/cytotron_clip_image001_0007.jpgProblem wounds healing
http://www.cytotron.com/images/cytotron_clip_image001_0008.jpgTinnitus
http://www.cytotron.com/images/cytotron_clip_image001_0009.jpgDrug resistant epilepsy


Dr. Nayar’s Paper
Quantum Magnetic Resonance Therapy (QMRT) using the Cytotron® is a recent and indigenous addition to the emerging technologies in the management of solid malignant tumors. The medical device can deliver highly complex quantum instantaneous nuclear magnetic resonance beams in the radio and sub-radio frequency range with a near field delivery using specialized antennae. Precise calculations are made by its computer, based on tissue proton density (PD) measurements obtained from specific axial PD sequences of MRI. The radio frequencies (RF) set up resonance in the protons of the hydrogen of water molecules in the tissues, which can alter the trans-membrane potential (TMP) of the tumor cells and their mitochondria to the specific requirements. In cancer cells the TMP is of the order of-20 to -30 mV instead of the normal - 70 to -90 mV seen in healthy cells. The normalized TMP results in the restoration of the normal communication channels for command and control of various cell functions. This arrests the uncontrolled process of cell division and multiplication seen in malignant cells and results in apoptosis. The process is mediated through gene expression of appropriate p53 and p73 groups of proteins synthesized by the mitochondria. The clinical trials using QMRT are giving increasing evidence in support of this hypothesis. There is an impressive record of increased cancer-free survival even in some very advanced cases of cancers, who otherwise could not have survived beyond a few days or weeks. This paper presents an overview of treatment, results, improvement in the quality of life in terminal cases, and the increasing international recognition for the device. The need for more multi-centric trials at our leading Cancer Centers is emphasized. 

No comments:

Post a Comment